← Back to Clinical Trials
Recruiting NCT06445140

NCT06445140 Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06445140
Status Recruiting
Phase —
Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 55 participants
Start Date 2024-06-18
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age 70 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Collecting the variables and Implementation of a behavioural intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 55 participants in total. It began in 2024-06-18 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Oncogeriatric: a collaboration between oncologists and geriatricians which aims to ensure that all elderly cancer patients receive treatment adapted to their condition, thanks to a multidisciplinary and multi-professional approach. This project aims to gain a better understanding of the motivational determinants of PA and nutrition in elderly cancer patients. It has a dual objective: 1. to identify clusters/groups in patients on the basis of daily motivational factors focusing on PA and nutrition 2. on the basis of the results obtained in (1), to propose an interventional study based on the previously established clusters, in order to examine the effects of a behavioral intervention on patients' adherence to PA and nutrition, both agreed according to an individualized goal and defined in agreement with the patient and the multidisciplinary team, taking into account the recommendations.

Eligibility Criteria

Inclusion Criteria: 1. Patient aged 70 or over 2. With cancer (solid tumors, all sites) 3. G8 ≤ 14 4. Inactive (patient not meeting recommended physical activity levels of 150 minutes per week at moderate intensity) 5. Patient has given informed, written and express consent 6. Patient affiliated to a French social security scheme. Exclusion Criteria: 1. Known presence of brain metastases 2. Inability to participate in digital platform assessments or physical tests 3. Inability to eat orally 4. Contraindication or inability to engage in physical activity 5. Patient unable to follow up regularly for psychological, family, numerical, social or geographical reasons 6. Person deprived of liberty or under protective custody or guardianship.

Contact & Investigator

Central Contact

MOUSSION AURORE

✉ aurore.moussion@icm.unicancer.fr

📞 0467613102

Principal Investigator

GALLET SUCHET BLANDINE

PRINCIPAL INVESTIGATOR

Institut du Cancer de Montpellier - Val d'Aurelle

Frequently Asked Questions

Who can join the NCT06445140 clinical trial?

This trial is open to participants of all sexes, aged 70 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06445140 currently recruiting?

Yes, NCT06445140 is actively recruiting participants. Contact the research team at aurore.moussion@icm.unicancer.fr for enrollment information.

Where is the NCT06445140 trial being conducted?

This trial is being conducted at Montpellier, France.

Who is sponsoring the NCT06445140 clinical trial?

NCT06445140 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. The principal investigator is GALLET SUCHET BLANDINE at Institut du Cancer de Montpellier - Val d'Aurelle. The trial plans to enroll 55 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology